Diagnostic utility of direct immunofluorescence test panels for cutaneous vasculitis: A scoping review
Journal of Cutaneous Pathology · 2024
DOI: 10.1111/cup.14722 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Julia S Lehman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Skin, Skin Diseases, Vascular, Vasculitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Background
Due to the immune‐mediated nature of non‐infectious cutaneous vasculitis, skin biopsy specimens are often submitted for direct immunofluorescence (DIF) testing when vasculitis is considered clinically. However, evidence regarding the clinical value of DIF has not been rigorously appraised.
Objective
In this scoping review, we aimed to systematically evaluate the peer‐reviewed literature on the utility of DIF in vasculitis to assist with the development of appropriate use criteria by the American Society of Dermatopathology.
Methods
Two electronic databases were searched for articles on DIF and vasculitis (January 1975–October 2023). Relevant case series involving more than or equal to three patients, published in English, and with full‐text availability were included. Additional articles were identified manually via reference review. Due to study heterogeneity, findings were analyzed descriptively.
Results
Of 255 articles identified, 61 met the inclusion criteria. Cumulatively representing over 1000 DIF specimens, several studies estimated DIF sensitivity to be 75%. While vascular immunoglobulin A (IgA) deposits on DIF were associated with renal disease, other systemic associations were inconsistent. Vascular IgG deposition may be overrepresented in ANCA‐associated vasculitis. Granular vascular and epidermal basement membrane zone Ig deposition differentiated hypocomplementemic from normocomplementemic urticarial vasculitis. Few studies have assessed the added value of DIF over routine microscopy alone in vasculitis.
Conclusions
This scoping review discovered that DIF testing for vasculitis has been performed not only for diagnostic confirmation of vasculitis but also for disease subtype classification and prediction of systemic associations. Future studies on test sensitivity of DIF compared to that of histopathology are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Dermatology, Geisinger Medical Center, Pennsylvania, USA.
- Department of Pathology, Geisinger Medical Center, Pennsylvania, USA.
- Department of Dermatology, University of California Davis, Sacramento, California, USA.
- Department of Pathology, University of California Davis, Sacramento, California, USA.
ORCID-Profile: Julia S Lehman, Maxwell A Fung
Zitieren
APA
Lehman, J. S., Ferringer, T. C., Fung, M. A., Cassarino, D. S., & Shalin, S. C. (2024). Diagnostic utility of direct immunofluorescence test panels for cutaneous vasculitis: A scoping review. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14722
Vancouver
Lehman JS, Ferringer TC, Fung MA, Cassarino DS, Shalin SC. Diagnostic utility of direct immunofluorescence test panels for cutaneous vasculitis: A scoping review. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14722
BibTeX
@article{Lehman2024,
author = {Lehman, Julia S and Ferringer, Tammie C and Fung, Maxwell A and Cassarino, David S and Shalin, Sara C},
title = {Diagnostic utility of direct immunofluorescence test panels for cutaneous vasculitis: A scoping review},
journal = {Journal of Cutaneous Pathology},
year = {2024},
doi = {10.1111/cup.14722}
}
EUVIMED